Guidotti A, Baraldi M, Costa E
Pharmacology. 1979;19(5):267-77. doi: 10.1159/000137322.
The high affinity receptors or GABA present in brain interact with an endogenous thermostable inhibitor (GABA modulin) which allosterically modifies GABA binding sites. This is the type of GABA receptor that we term GABA2 receptor in comparison to GABA1 receptor which has low affinity for GABA and is not regulated by GABA modulin. The 1,4-benzodiazepines interact competitively with GABA modulin and thereby modify GABA2 receptor binding. In contrast the occupancy of GABA receptor increases the affinity of 1,4-benzodiazepine receptors for their specific agonist. The GABA modulin and both GABA receptors are located on the membranes of C6 and NB2a cells. The NB2a cell membranes also contain CL- ionophore, thus the complete receptor complex is present in the membranes of NB2a cell clone. It was proposed that the inability of clonazepam to displace 3H-diazepam from specific binding sites characterizes the nonneuronal 1,4-benzodiazepine receptor. This characterization was shown to relate to the properties of other membrane components rather than to the characteristics of the specific benzodiazepine receptors.
大脑中存在的高亲和力γ-氨基丁酸(GABA)受体与一种内源性热稳定抑制剂(GABA调节蛋白)相互作用,该抑制剂可别构修饰GABA结合位点。与对GABA亲和力低且不受GABA调节蛋白调控的GABA1受体相比,我们将这种类型的GABA受体称为GABA2受体。1,4-苯二氮䓬类药物与GABA调节蛋白竞争性相互作用,从而改变GABA2受体的结合。相反,GABA受体的占据会增加1,4-苯二氮䓬受体对其特异性激动剂的亲和力。GABA调节蛋白和两种GABA受体都位于C6和NB2a细胞的膜上。NB2a细胞膜还含有氯离子载体,因此完整的受体复合物存在于NB2a细胞克隆的膜中。有人提出,氯硝西泮无法从特异性结合位点取代3H-地西泮,这是无神经元1,4-苯二氮䓬受体的特征。已表明这种特征与其他膜成分的特性有关,而不是与特异性苯二氮䓬受体的特性有关。